Home/Filings/4/0000874015-25-000216
4//SEC Filing

WENDER JOSEPH H 4

Accession 0000874015-25-000216

CIK 0000874015other

Filed

Sep 3, 8:00 PM ET

Accepted

Sep 4, 8:34 PM ET

Size

9.5 KB

Accession

0000874015-25-000216

Insider Transaction Report

Form 4
Period: 2025-09-02
Transactions
  • Sale

    Common Stock

    2025-09-03$60.14/sh11,200$673,549108,835 total(indirect: By Trust)
  • Sale

    Common Stock

    2025-09-02$57.53/sh5,600$322,174120,035 total(indirect: By Trust)
  • Sale

    Common Stock

    2025-09-02$55.04/sh11,200$616,432125,635 total(indirect: By Trust)
Footnotes (4)
  • [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 16, 2024.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.000 to $55.180 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.500 to $57.575 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.53 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) on this Form 4.

Issuer

IONIS PHARMACEUTICALS INC

CIK 0000874015

Entity typeother

Related Parties

1
  • filerCIK 0001073384

Filing Metadata

Form type
4
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 8:34 PM ET
Size
9.5 KB